Short answer
SANUWAVE Health, Inc. (SNWV) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results released for quarter ended June 30, 2026.
SANUWAVE Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results released for quarter ended June 30, 2026
- Investor conference call scheduled August 7, 2026 at 8:30 a.m. EST
- Detailed results and business update available through the company’s investor website
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $9.7M, down 3%; gross margin fell to 76.2% from 78.1%
- Ultramist systems sold declined to 82 from 116, while applicator revenue rose 13% to $7.3M
- GAAP operating loss $(0.3)M and net loss $0.7M, versus operating income $1.4M and net income $0.6M
- Adjusted EBITDA dropped to $1.2M from $3.2M, signaling materially weaker operating profitability
- FY2026 guidance withdrawn pending CMS’s 2027 reimbursement final rule, expected in Q4 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SANUWAVE Health, Inc. 8-K filings
Get the next SNWV 8-K as it lands
Follow SNWV for push alerts, or ask the research agent what this filing means.